Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$56.53
-1.58%
Mkt Cap $14.83B
Analyst Ratings
Buy
3
Hold
12
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
Implied Upside
-11.6%
Consensus $50.00 vs current $56.53
NASDAQ·Healthcare·Biotechnology
$56.53
-1.58%
Mkt Cap $14.83B
Buy
3
Hold
12
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
-11.6%
Consensus $50.00 vs current $56.53